Cargando…
An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid
Stroke is the second leading cause of death after heart disease globally and cerebral ischemic stroke accounts for approximately 70% of all incident stroke cases. We selected four main compounds from a patent Chinese medicine, Qingkailing (QKL) injection, including baicalin from Scutellaria baicalen...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227481/ https://www.ncbi.nlm.nih.gov/pubmed/32457601 http://dx.doi.org/10.3389/fphar.2020.00519 |
_version_ | 1783534504863858688 |
---|---|
author | Ma, Chongyang Wang, Xueqian Xu, Tian Zhang, Shuang Liu, Shuling Zhai, Changming Wang, Zisong Mu, Jie Li, Changxiang Cheng, Fafeng Wang, Qingguo |
author_facet | Ma, Chongyang Wang, Xueqian Xu, Tian Zhang, Shuang Liu, Shuling Zhai, Changming Wang, Zisong Mu, Jie Li, Changxiang Cheng, Fafeng Wang, Qingguo |
author_sort | Ma, Chongyang |
collection | PubMed |
description | Stroke is the second leading cause of death after heart disease globally and cerebral ischemic stroke accounts for approximately 70% of all incident stroke cases. We selected four main compounds from a patent Chinese medicine, Qingkailing (QKL) injection, including baicalin from Scutellaria baicalensis Georgi (Huang Qin), geniposide from Gardenia jasminoides J. Ellis (Zhizi), and cholic acid and hyodeoxycholic acid from Bovis Calculus (Niuhuang) with a ratio of 4.4:0.4:3:2.6 m/m, to develop a more efficacious and safer modern Chinese medicine injection against ischemic stroke, refined QKL (RQKL). In this study, we investigated multiple targets, levels, and pathways of RQKL by using an integrative pharm\acology combining experimental validation approach. In silica study showed that RQKL may regulate PI3K-Akt, estrogen, neurotrophin, HIF-1, MAPK, Hippo, FoxO, TGF-beta, NOD-like receptor, apoptosis, NF-kappa B, Wnt, chemokine, TNF, Toll-like receptor signaling pathways against ischemic stroke. The experimental results showed that RQKL improved neurological function and prevented infract volume and blood-brain-barrier damage. RQKL inhibited microgliosis and astrogliosis, and protected neurons from ischemic/reperfusion injury. RQKL also inhibited cell apoptosis and affecting the ratio of the anti-apoptosis protein B-cell lymphoma-2 (Bcl2) and pro-apoptosis protein Bcl2-associated X protein (Bax). Western blot analysis showed that RQKL activated AKT/PI3K signaling pathway and antibody array showed RQKL inhibited inflammatory response and decreased proinflammatory factor Tnf, Il6, and Il1b, and chemokines Ccl2, Cxcl2, and Cxcl3, and increased anti-inflammatory cytokine Il10. In conclusion, RQKL protected tissue against ischemic stroke through multiple-target, multiple signals, and modulating multiple cell-types in brain. This study not only promoted our understanding of the role of RQKL against ischemic stroke, but also provided a pattern for the study of Chinese medicine combining pharmaceutical Informatics and system biology methods. |
format | Online Article Text |
id | pubmed-7227481 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72274812020-05-25 An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid Ma, Chongyang Wang, Xueqian Xu, Tian Zhang, Shuang Liu, Shuling Zhai, Changming Wang, Zisong Mu, Jie Li, Changxiang Cheng, Fafeng Wang, Qingguo Front Pharmacol Pharmacology Stroke is the second leading cause of death after heart disease globally and cerebral ischemic stroke accounts for approximately 70% of all incident stroke cases. We selected four main compounds from a patent Chinese medicine, Qingkailing (QKL) injection, including baicalin from Scutellaria baicalensis Georgi (Huang Qin), geniposide from Gardenia jasminoides J. Ellis (Zhizi), and cholic acid and hyodeoxycholic acid from Bovis Calculus (Niuhuang) with a ratio of 4.4:0.4:3:2.6 m/m, to develop a more efficacious and safer modern Chinese medicine injection against ischemic stroke, refined QKL (RQKL). In this study, we investigated multiple targets, levels, and pathways of RQKL by using an integrative pharm\acology combining experimental validation approach. In silica study showed that RQKL may regulate PI3K-Akt, estrogen, neurotrophin, HIF-1, MAPK, Hippo, FoxO, TGF-beta, NOD-like receptor, apoptosis, NF-kappa B, Wnt, chemokine, TNF, Toll-like receptor signaling pathways against ischemic stroke. The experimental results showed that RQKL improved neurological function and prevented infract volume and blood-brain-barrier damage. RQKL inhibited microgliosis and astrogliosis, and protected neurons from ischemic/reperfusion injury. RQKL also inhibited cell apoptosis and affecting the ratio of the anti-apoptosis protein B-cell lymphoma-2 (Bcl2) and pro-apoptosis protein Bcl2-associated X protein (Bax). Western blot analysis showed that RQKL activated AKT/PI3K signaling pathway and antibody array showed RQKL inhibited inflammatory response and decreased proinflammatory factor Tnf, Il6, and Il1b, and chemokines Ccl2, Cxcl2, and Cxcl3, and increased anti-inflammatory cytokine Il10. In conclusion, RQKL protected tissue against ischemic stroke through multiple-target, multiple signals, and modulating multiple cell-types in brain. This study not only promoted our understanding of the role of RQKL against ischemic stroke, but also provided a pattern for the study of Chinese medicine combining pharmaceutical Informatics and system biology methods. Frontiers Media S.A. 2020-05-08 /pmc/articles/PMC7227481/ /pubmed/32457601 http://dx.doi.org/10.3389/fphar.2020.00519 Text en Copyright © 2020 Ma, Wang, Xu, Zhang, Liu, Zhai, Wang, Mu, Li, Cheng and Wang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Ma, Chongyang Wang, Xueqian Xu, Tian Zhang, Shuang Liu, Shuling Zhai, Changming Wang, Zisong Mu, Jie Li, Changxiang Cheng, Fafeng Wang, Qingguo An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid |
title | An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid |
title_full | An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid |
title_fullStr | An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid |
title_full_unstemmed | An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid |
title_short | An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid |
title_sort | integrative pharmacology-based analysis of refined qingkailing injection against cerebral ischemic stroke: a novel combination of baicalin, geniposide, cholic acid, and hyodeoxycholic acid |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227481/ https://www.ncbi.nlm.nih.gov/pubmed/32457601 http://dx.doi.org/10.3389/fphar.2020.00519 |
work_keys_str_mv | AT machongyang anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT wangxueqian anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT xutian anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT zhangshuang anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT liushuling anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT zhaichangming anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT wangzisong anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT mujie anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT lichangxiang anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT chengfafeng anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT wangqingguo anintegrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT machongyang integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT wangxueqian integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT xutian integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT zhangshuang integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT liushuling integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT zhaichangming integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT wangzisong integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT mujie integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT lichangxiang integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT chengfafeng integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid AT wangqingguo integrativepharmacologybasedanalysisofrefinedqingkailinginjectionagainstcerebralischemicstrokeanovelcombinationofbaicalingeniposidecholicacidandhyodeoxycholicacid |